Basal-bolus insulin therapy for the treatment of non-critically ill patients with type 2 diabetes in Vietnam: effectiveness and factors associated with inpatient glycemic control

ConclusionBBIT is safe and effective for the treatment of IGC in non-critically ill patients. Moreover, eGFR<45 mL/min/1.73 m2 at admission, snack consumption, and GC therapy were independent factors associated with IGC outcomes.
Source: International Journal of Diabetes in Developing Countries - Category: Endocrinology Source Type: research